Evaluating the effects of the World Health Organization's online intervention ‘iSupport’ to reduce depression and distress in dementia carers: a multi-centre six-month randomised controlled trial in the UK
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
Fersiynau electronig
Dogfennau
- 1-s2.0-S266677622400293X-main
Fersiwn derfynol wedi’i chyhoeddi, 380 KB, dogfen-PDF
Trwydded: CC BY-NC-ND Dangos trwydded
Dangosydd eitem ddigidol (DOI)
Background Sustaining the capabilities of dementia carers is a global priority. ‘iSupport’ is a self-guided online
intervention designed by the World Health Organization (WHO) to reduce mental health problems in dementia
carers. iSupport is undergoing global implementation, however there is an absence of effectiveness evidence. This
study tested the effectiveness of iSupport to reduce distress and depression in dementia carers.
Methods A pragmatic randomised controlled trial was conducted in three centres. Adult carers (18+) living in the
community were recruited in England, Wales and Scotland and randomly assigned (1:1) through a web-based
system to iSupport or usual care. Outcome assessors were masked to allocation. The primary outcomes
assessed the difference in distress and depression between baseline and six-months. The target sample size
was 350 to enable 90% power, significance at 2.5% including 25% attrition (262 completers) on either
outcome. Analysis followed the intention-to-treat (ITT) principle. The trial was registered with ISRCTN
registry (17420703).
Findings Between 12th November 2021 and 31st March 2023,177 carers (50.3%) were randomised to usual care and
175 (49.7%) to iSupport. 263 (74.7%) completed the trial. All were included in the ITT analysis. Mean distress scores
at six-months were 20.0 (SD = 8.3) for usual care and 20.6 (SD = 8.6) for iSupport. The mean difference was 0.16 (95%
CI −1.17 to 1.49, p = 0.29) after adjusting for covariates. Mean depression scores at six-months were 9.5 (SD = 7.0) for
usual care and 9.8 (SD = 6.5) for iSupport. The mean difference at six-months was −0.54 (95% CI = −1.70 to 0.62,
p = 0.44). No serious adverse events were linked to the trial.
Interpretation To our knowledge this is the largest trial evaluating a self-guided online intervention in UK dementia
carers, and the first to successfully evaluate the effectiveness of iSupport. The null findings are significant given the
ongoing global implementation of iSupport by the WHO and the adoption of self-guided interventions into
mainstream care delivery as part of digital health transformations.
Funding NIHR.
intervention designed by the World Health Organization (WHO) to reduce mental health problems in dementia
carers. iSupport is undergoing global implementation, however there is an absence of effectiveness evidence. This
study tested the effectiveness of iSupport to reduce distress and depression in dementia carers.
Methods A pragmatic randomised controlled trial was conducted in three centres. Adult carers (18+) living in the
community were recruited in England, Wales and Scotland and randomly assigned (1:1) through a web-based
system to iSupport or usual care. Outcome assessors were masked to allocation. The primary outcomes
assessed the difference in distress and depression between baseline and six-months. The target sample size
was 350 to enable 90% power, significance at 2.5% including 25% attrition (262 completers) on either
outcome. Analysis followed the intention-to-treat (ITT) principle. The trial was registered with ISRCTN
registry (17420703).
Findings Between 12th November 2021 and 31st March 2023,177 carers (50.3%) were randomised to usual care and
175 (49.7%) to iSupport. 263 (74.7%) completed the trial. All were included in the ITT analysis. Mean distress scores
at six-months were 20.0 (SD = 8.3) for usual care and 20.6 (SD = 8.6) for iSupport. The mean difference was 0.16 (95%
CI −1.17 to 1.49, p = 0.29) after adjusting for covariates. Mean depression scores at six-months were 9.5 (SD = 7.0) for
usual care and 9.8 (SD = 6.5) for iSupport. The mean difference at six-months was −0.54 (95% CI = −1.70 to 0.62,
p = 0.44). No serious adverse events were linked to the trial.
Interpretation To our knowledge this is the largest trial evaluating a self-guided online intervention in UK dementia
carers, and the first to successfully evaluate the effectiveness of iSupport. The null findings are significant given the
ongoing global implementation of iSupport by the WHO and the adoption of self-guided interventions into
mainstream care delivery as part of digital health transformations.
Funding NIHR.
Iaith wreiddiol | Saesneg |
---|---|
Rhif yr erthygl | 101125 |
Cyfnodolyn | Lancet Regional Health - Europe |
Cyfrol | 48 |
Dyddiad ar-lein cynnar | 20 Tach 2024 |
Dynodwyr Gwrthrych Digidol (DOIs) | |
Statws | E-gyhoeddi cyn argraffu - 20 Tach 2024 |